Elanco Boosts Vaccine Portfolio With $60M Prevtec Acquisition

Elanco Boosts Vaccine Portfolio With $60M Prevtec Acquisition

Source: 
Xconomy
snippet: 

One of the most serious threats to a young farm pig’s life is a type of gut infection that can quickly turn deadly. Elanco Animal Health has acquired a Canadian biotechnology startup that has commercialized a line of vaccines developed to protect pigs from the infection.